Yibin Tianyuan Group Co., Ltd.

Informe acción SZSE:002386

Capitalización de mercado: CN¥5.8b

Yibin Tianyuan Group Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Yibin Tianyuan Group has been growing earnings at an average annual rate of 0.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been declining at an average rate of 6.2% per year.

Información clave

0.1%

Tasa de crecimiento de los beneficios

-0.5%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals 12.1%
Tasa de crecimiento de los ingresos-6.2%
Rentabilidad financiera-1.4%
Margen neto-0.7%
Última actualización de beneficios30 Sep 2024

Actualizaciones de resultados anteriores recientes

Yibin Tianyuan Group's (SZSE:002386) Anemic Earnings Might Be Worse Than You Think

May 10
Yibin Tianyuan Group's (SZSE:002386) Anemic Earnings Might Be Worse Than You Think

Recent updates

Is Yibin Tianyuan Group (SZSE:002386) Using Debt In A Risky Way?

Aug 01
Is Yibin Tianyuan Group (SZSE:002386) Using Debt In A Risky Way?

Yibin Tianyuan Group's (SZSE:002386) Anemic Earnings Might Be Worse Than You Think

May 10
Yibin Tianyuan Group's (SZSE:002386) Anemic Earnings Might Be Worse Than You Think

Why Investors Shouldn't Be Surprised By Yibin Tianyuan Group Co., Ltd.'s (SZSE:002386) Low P/S

Apr 17
Why Investors Shouldn't Be Surprised By Yibin Tianyuan Group Co., Ltd.'s (SZSE:002386) Low P/S

Returns On Capital At Yibin Tianyuan Group (SZSE:002386) Paint A Concerning Picture

Mar 12
Returns On Capital At Yibin Tianyuan Group (SZSE:002386) Paint A Concerning Picture

Desglose de ingresos y gastos

Cómo gana y gasta dinero Yibin Tianyuan Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

SZSE:002386 Ingresos, gastos y beneficios (CNY Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
30 Sep 2412,757-83563101
30 Jun 2413,18940566101
31 Mar 2417,640-1454791
31 Dec 2318,3674052799
30 Sep 2322,01675378123
30 Jun 2322,838144440111
31 Mar 2320,175440459103
01 Jan 2320,33955150193
30 Sep 2220,12665355473
30 Jun 2219,23074954961
31 Mar 2218,31869553438
01 Jan 2218,82564553361
30 Sep 2118,45759336158
30 Jun 2121,832472416102
31 Mar 2122,848255519168
31 Dec 2021,646116483156
30 Sep 2019,78015714169
30 Jun 2020,278-49745180
31 Mar 2021,56814645166
31 Dec 1923,10379719172
30 Sep 1923,64785710149
30 Jun 1921,118135680141
31 Mar 1919,889152687151
31 Dec 1818,123155665154
30 Sep 1819,02216665631
30 Jun 1817,88518261089
31 Mar 1816,05914158944
31 Dec 1715,2861035658
30 Sep 1713,542189593100
30 Jun 1712,6561465870
31 Mar 1713,1091215700
31 Dec 1612,502555580
30 Sep 1613,693895130
30 Jun 1613,747365150
31 Mar 1610,985214710
31 Dec 1510,704164540
30 Sep 158,821184850
30 Jun 158,014144820
31 Mar 158,826-35150
31 Dec 149,184615000
30 Sep 149,192-894030
30 Jun 149,270-424040
31 Mar 149,073274030
31 Dec 139,152564130

Ingresos de calidad: 002386 is currently unprofitable.

Margen de beneficios creciente: 002386 is currently unprofitable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: 002386 is unprofitable, but has reduced losses over the past 5 years at a rate of 0.1% per year.

Acelerando crecimiento: Unable to compare 002386's earnings growth over the past year to its 5-year average as it is currently unprofitable

Beneficios vs. Industria: 002386 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.8%).


Rentabilidad financiera

Alta ROE: 002386 has a negative Return on Equity (-1.42%), as it is currently unprofitable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado